Top news from MedWatch this week
![Photo: MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12791283.ece/ALTERNATES/schema-16_9/doc7eok1wt4jdl13ye5emaw.jpg)
Monday
WS Audiology closes factory, lets 189 employees go
Ambu CEO wants more women in leadership
Tuesday
Demant establishes innovation unit in Kuala Lumpur
EU blocks Illumina acquisition of Grail
Leo Pharma’s energy contingency plan approved
Wednesday
Novo Nordisk licenses hypoglycemia drug from Zealand Pharma
Zealand CEO: Novo Nordisk is ”the perfect partner” to market rescue pen
Analyst: Zegalogue launch should be ”plug and play” for Novo Nordisk
Zealand Pharma intensifies partner hunt for other drug candidates
Bavarian Nordic raises expectations after another EU monkeypox vaccine order
Coloplast has a cost problem, says EVP of global operations
Thursday
Leo Pharma leaves the door open for acquisitions
Leo Pharma CEO: ”The strategy has started to crystalize and yield a return”
Friday
Coloplast’s new factories in Costa Rica will increase salary savings and reduce climate footprint
Novo Nordisk to launch cheaper version of long-acting insulin in US
Former Ambu employee stands trial for alleged insider trading